IL108892A - Azacyclohexapeptide compounds and bactericidal preparations containing them - Google Patents
Azacyclohexapeptide compounds and bactericidal preparations containing themInfo
- Publication number
- IL108892A IL108892A IL10889294A IL10889294A IL108892A IL 108892 A IL108892 A IL 108892A IL 10889294 A IL10889294 A IL 10889294A IL 10889294 A IL10889294 A IL 10889294A IL 108892 A IL108892 A IL 108892A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- seq
- xaa xaa
- ch2ch2nh2
- ch2conh2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Chemical Vapour Deposition (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/032,847 US5378804A (en) | 1993-03-16 | 1993-03-16 | Aza cyclohexapeptide compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
IL108892A0 IL108892A0 (en) | 1994-06-24 |
IL108892A true IL108892A (en) | 1998-07-15 |
Family
ID=21867140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10889294A IL108892A (en) | 1993-03-16 | 1994-03-08 | Azacyclohexapeptide compounds and bactericidal preparations containing them |
Country Status (33)
Country | Link |
---|---|
US (3) | US5378804A (fr) |
EP (1) | EP0620232B1 (fr) |
JP (1) | JP2568474B2 (fr) |
KR (1) | KR100329693B1 (fr) |
CN (1) | CN1098274C (fr) |
AT (1) | ATE186736T1 (fr) |
AU (1) | AU668804B2 (fr) |
BG (1) | BG63047B1 (fr) |
BR (2) | BR9406009A (fr) |
CA (1) | CA2118757C (fr) |
CZ (1) | CZ286235B6 (fr) |
DE (2) | DE10299013I2 (fr) |
DK (1) | DK0620232T3 (fr) |
ES (1) | ES2139043T3 (fr) |
FI (1) | FI109542B (fr) |
GR (1) | GR3031872T3 (fr) |
HK (1) | HK1008674A1 (fr) |
HR (1) | HRP940161B1 (fr) |
HU (2) | HU217614B (fr) |
IL (1) | IL108892A (fr) |
LU (1) | LU90875I2 (fr) |
LV (1) | LV12574B (fr) |
NL (1) | NL300076I2 (fr) |
NO (2) | NO318372B1 (fr) |
NZ (1) | NZ263360A (fr) |
PL (1) | PL179261B1 (fr) |
RO (1) | RO113246B1 (fr) |
RU (1) | RU2122548C1 (fr) |
SI (1) | SI9420013B (fr) |
SK (1) | SK282527B6 (fr) |
UA (1) | UA59329C2 (fr) |
WO (1) | WO1994021677A1 (fr) |
ZA (1) | ZA941807B (fr) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874403A (en) * | 1992-10-15 | 1999-02-23 | Merck & Co., Inc. | Amino acid conjugates of cyclohexapeptidyl amines |
US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5948753A (en) * | 1993-05-04 | 1999-09-07 | Merck & Co., Inc. | Cyclohexapeptidyl propanolamine compounds |
WO1996006109A1 (fr) * | 1994-08-23 | 1996-02-29 | Merck & Co., Inc. | Procede ameliore pour preparer des derives de lipopeptides cyclohexapeptidiques ayant des chaines laterales |
AU692308B2 (en) * | 1994-09-16 | 1998-06-04 | Merck Sharp & Dohme Corp. | Aza cyclohexapeptide compounds |
US5516757A (en) * | 1994-09-16 | 1996-05-14 | Merck & Co., Inc. | Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use |
US5514651A (en) * | 1994-09-16 | 1996-05-07 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5516756A (en) * | 1994-10-31 | 1996-05-14 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
EP0805685B1 (fr) * | 1995-01-26 | 2001-09-26 | Merck & Co., Inc. | Nouveaux cyclohexapeptides antifongiques |
US5552521A (en) * | 1995-02-10 | 1996-09-03 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
AU707664B2 (en) * | 1995-11-09 | 1999-07-15 | Merck & Co., Inc. | Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
US5952300A (en) * | 1996-04-19 | 1999-09-14 | Merck & Co., Inc. | Antifungal compositions |
AR006598A1 (es) * | 1996-04-19 | 1999-09-08 | Merck Sharp & Dohme | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" |
HRP970318B1 (en) * | 1996-06-14 | 2002-06-30 | Merck & Co Inc | A process for preparing certain aza cyclohexapeptides |
CA2265824C (fr) * | 1996-09-12 | 2004-11-09 | Merck & Co., Inc. | Therapie antifongique combinee |
USRE38984E1 (en) * | 1996-09-12 | 2006-02-14 | Merck & Co., Inc. | Antifungal combination therapy |
US5854212A (en) * | 1996-10-23 | 1998-12-29 | Merck & Co., Inc. | Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
US5936062A (en) * | 1997-06-12 | 1999-08-10 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
WO2001007468A2 (fr) * | 1999-07-27 | 2001-02-01 | Aventis Pharma Deutschland Gmbh | Nouveaux composes cyclohexapeptides, procedes de production et utilisation de ces derniers comme produit pharmaceutique |
AR035808A1 (es) * | 2001-04-12 | 2004-07-14 | Merck & Co Inc | Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas |
JP4625637B2 (ja) | 2002-02-22 | 2011-02-02 | シャイア エルエルシー | 活性物質送達系及び活性物質を保護し投与する方法 |
US7214768B2 (en) * | 2002-04-08 | 2007-05-08 | Merck & Co., Inc. | Echinocandin process |
DE602004010915T2 (de) * | 2003-07-22 | 2008-12-11 | Theravance, Inc., South San Francisco | Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel |
EP1730180A4 (fr) * | 2004-02-24 | 2008-06-18 | Commw Scient Ind Res Org | Peptides antifongiques |
EP1785432A1 (fr) | 2005-11-15 | 2007-05-16 | Sandoz AG | Procédé et produits intermédiaires pour la synthèse du caspofungin. |
WO2008012310A1 (fr) | 2006-07-26 | 2008-01-31 | Sandoz Ag | Préparations à base de caspofungine |
TW200826957A (en) * | 2006-10-16 | 2008-07-01 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Purification processes for echinocandin-type compounds |
CA2692053A1 (fr) | 2007-06-26 | 2008-12-31 | Merck Sharp & Dohme Corp. | Composition antifongique lyophilisee |
US20090075870A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched caspofungin |
US20090291996A1 (en) * | 2008-05-21 | 2009-11-26 | Ferenc Korodi | Caspofungin free of caspofungin Co |
US8048853B2 (en) * | 2008-06-13 | 2011-11-01 | Xellia Pharmaceuticals Aps | Process for preparing pharmaceutical compound and intermediates thereof |
EP2240507A2 (fr) * | 2008-06-25 | 2010-10-20 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Procédés pour préparer des azacyclohexapeptides de pureté élevée |
EP2183271A1 (fr) * | 2008-06-25 | 2010-05-12 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Caspofungine débarrassée de l'impureté a des caspofungines |
WO2010064219A1 (fr) | 2008-12-04 | 2010-06-10 | Ranbaxy Laboratories Limited | Procédé de préparation d'un nouvel intermédiaire de la caspofungine |
TW201024322A (en) * | 2008-12-31 | 2010-07-01 | Chunghwa Chemical Synthesis & Biotech Co Ltd | Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate |
WO2010108637A1 (fr) | 2009-03-27 | 2010-09-30 | Axellia Pharmaceuticals Aps | Composé cristallisé |
CN101602795B (zh) * | 2009-07-20 | 2011-12-21 | 中国人民解放军第二军医大学 | 环六脂肽胺类抗真菌化合物及其盐类和制备方法 |
EP2463293A4 (fr) * | 2009-08-06 | 2013-06-05 | Shanghai Techwell Biopharm Co | Azacyclohexapeptide ou son sel pharmaceutiquement acceptable, procédé de préparation et utilisation afférente |
US8751760B2 (en) * | 2009-10-01 | 2014-06-10 | Dell Products L.P. | Systems and methods for power state transitioning in an information handling system |
CN101792486A (zh) * | 2010-04-12 | 2010-08-04 | 浙江海正药业股份有限公司 | 一种合成醋酸卡泊芬净的方法 |
CN102219832B (zh) * | 2010-04-15 | 2013-08-21 | 上海天伟生物制药有限公司 | 一种氮杂环六肽或其盐的纯化方法 |
AU2011304408B2 (en) | 2010-09-20 | 2015-01-15 | Xellia Pharmaceuticals Aps | Caspofungin composition |
CA2813330A1 (fr) * | 2010-09-29 | 2012-04-05 | Shanghai Techwell Biopharmaceutical Co., Ltd. | Procede de purification de composes lipopeptides cycliques ou de leurs sels |
EP2623611B1 (fr) * | 2010-09-30 | 2016-07-13 | Shanghai Techwell Biopharmaceutical Co., Ltd | Procédé de purification d'un lipopeptide cyclique ou de son sel |
CN102367268B (zh) | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其用途 |
CN102367267B (zh) | 2010-11-10 | 2013-09-04 | 上海天伟生物制药有限公司 | 一种卡泊芬净的制备方法 |
CN102367269B (zh) | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其制备方法和用途 |
KR101331984B1 (ko) | 2010-12-09 | 2013-11-25 | 종근당바이오 주식회사 | 카스포펀진 제조방법 및 그의 신규 중간체 |
EP2661441A4 (fr) * | 2011-01-03 | 2015-04-08 | Biocon Ltd | Procédé de préparation d'acétate de caspofungine et de ses intermédiaires |
CN102618606B (zh) * | 2011-01-30 | 2014-09-10 | 浙江海正药业股份有限公司 | 一种棘白菌素生物转化方法 |
RS56426B1 (sr) | 2011-03-03 | 2018-01-31 | Cidara Therapeutics Inc | Antigljivična sredstva i njihova upotreba |
CN102746384B (zh) | 2011-04-22 | 2016-01-20 | 上海天伟生物制药有限公司 | 一种高纯度的卡泊芬净或其盐及其制备方法和用途 |
KR20140042805A (ko) | 2011-04-28 | 2014-04-07 | 유니트리스 바이오파마 컴퍼니 리미티드 | 카스포펀진 합성을 위한 중간체 및 그 제조 방법 |
JP6117907B2 (ja) | 2012-03-19 | 2017-04-19 | シダラ セラピューティクス インコーポレーテッド | エキノキャンディン系化合物のための投与レジメン |
PT2922530T (pt) | 2012-11-20 | 2016-12-22 | Fresenius Kabi Usa Llc | Formulações de acetato de caspofungina |
CN112110991A (zh) * | 2014-12-24 | 2020-12-22 | 上海天伟生物制药有限公司 | 一种含氮杂环六肽前体的组合物及其制备方法和用途 |
US9675659B2 (en) | 2015-08-21 | 2017-06-13 | Trilogy Therapeutics, Inc. | Methods of treating lung infection with caspofungin |
US10369188B2 (en) | 2016-01-08 | 2019-08-06 | Cidara Therapeutics, Inc. | Methods for preventing and treating pneumocystis infections |
EP3430400B1 (fr) | 2016-03-16 | 2023-06-21 | Cidara Therapeutics, Inc. | Schémas posologiques pour le traitement d'infections fongiques |
WO2017185030A1 (fr) * | 2016-04-22 | 2017-10-26 | Fresenius Kabi Usa, Llc | Formulation de caspofungine à faible taux d'impuretés |
CA3069423A1 (fr) | 2017-07-12 | 2019-01-17 | Cidara Therapeutics, Inc. | Formulations pour le traitement des infections fongiques |
WO2019157453A1 (fr) | 2018-02-12 | 2019-08-15 | Trilogy Therapeutics, Inc. | Compositions de caspofongine pour inhalation |
EP3620462A1 (fr) | 2018-09-04 | 2020-03-11 | Xellia Pharmaceuticals ApS | Procédé de préparation de caspofungine |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2704030A1 (de) * | 1976-02-12 | 1977-08-18 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
BE851310A (fr) * | 1976-02-12 | 1977-08-10 | Sandoz Sa | Nouveaux derives de la tetrahydro-equinocandine b |
DE2742435A1 (de) * | 1976-09-28 | 1978-04-06 | Sandoz Ag | Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung |
US4293489A (en) * | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4287120A (en) * | 1979-12-13 | 1981-09-01 | Eli Lilly And Company | Derivatives of S31794/F-1 nucleus |
US4320053A (en) * | 1979-12-13 | 1982-03-16 | Eli Lilly And Company | Derivatives of A-30912D nucleus |
US4293485A (en) * | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of S31794/F-1 nucleus |
GB2065130A (en) * | 1979-12-13 | 1981-06-24 | Lilly Co Eli | Recovery process for a-30912 antibiotics |
DE3030554A1 (de) * | 1980-08-13 | 1982-03-25 | Chemische Werke Hüls AG, 4370 Marl | Einbrennlacke |
US4931352A (en) * | 1987-10-07 | 1990-06-05 | Merck & Co., Inc. | Antifungal fermentation product |
US5166135A (en) * | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
DK173802B1 (da) * | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
US5021341A (en) * | 1990-03-12 | 1991-06-04 | Merck & Co., Inc. | Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol |
US5194377A (en) * | 1989-06-30 | 1993-03-16 | Merck & Co., Inc. | Antibiotic agent |
US5202309A (en) * | 1989-06-30 | 1993-04-13 | Merck & Co., Inc. | Antibiotic cyclopeptide fermentation product |
IL94862A (en) * | 1989-06-30 | 1994-10-07 | Merck & Co Inc | History of Echinocandin Antifungal Antibiotics, Its Production and Pharmaceutical Preparations Containing It |
GB8925593D0 (en) * | 1989-11-13 | 1990-01-04 | Fujisawa Pharmaceutical Co | Fr901379 substance and preparation thereof |
US5159059A (en) * | 1990-05-29 | 1992-10-27 | Merck & Co., Inc. | Process for reduction of certain cyclohexapeptide compounds |
IL105048A (en) * | 1992-03-19 | 2001-06-14 | Eli Lilly And Company U S | Antifungal substances of the cyclic peptide type and a process for their preparation |
US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5516757A (en) * | 1994-09-16 | 1996-05-14 | Merck & Co., Inc. | Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use |
US5516756A (en) * | 1994-10-31 | 1996-05-14 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
-
1993
- 1993-03-16 US US08/032,847 patent/US5378804A/en not_active Expired - Lifetime
-
1994
- 1994-03-08 IL IL10889294A patent/IL108892A/en not_active IP Right Cessation
- 1994-03-09 EP EP94200604A patent/EP0620232B1/fr not_active Expired - Lifetime
- 1994-03-09 DK DK94200604T patent/DK0620232T3/da active
- 1994-03-09 ES ES94200604T patent/ES2139043T3/es not_active Expired - Lifetime
- 1994-03-09 AT AT94200604T patent/ATE186736T1/de active
- 1994-03-09 DE DE10299013C patent/DE10299013I2/de active Active
- 1994-03-09 DE DE69421639T patent/DE69421639T2/de not_active Expired - Lifetime
- 1994-03-10 CZ CZ19952358A patent/CZ286235B6/cs not_active IP Right Cessation
- 1994-03-10 NZ NZ263360A patent/NZ263360A/xx not_active IP Right Cessation
- 1994-03-10 CN CN94191487A patent/CN1098274C/zh not_active Expired - Lifetime
- 1994-03-10 HU HU9502703A patent/HU217614B/hu unknown
- 1994-03-10 PL PL94310634A patent/PL179261B1/pl unknown
- 1994-03-10 HR HR940161A patent/HRP940161B1/xx not_active IP Right Cessation
- 1994-03-10 CA CA002118757A patent/CA2118757C/fr not_active Expired - Lifetime
- 1994-03-10 SI SI9420013A patent/SI9420013B/sl unknown
- 1994-03-10 RO RO95-01594A patent/RO113246B1/ro unknown
- 1994-03-10 BR BR9406009A patent/BR9406009A/pt not_active Application Discontinuation
- 1994-03-10 SK SK1136-95A patent/SK282527B6/sk not_active IP Right Cessation
- 1994-03-10 KR KR1019950703954A patent/KR100329693B1/ko active IP Right Grant
- 1994-03-10 WO PCT/US1994/002580 patent/WO1994021677A1/fr active IP Right Grant
- 1994-03-10 RU RU95121639A patent/RU2122548C1/ru active
- 1994-03-15 ZA ZA941807A patent/ZA941807B/xx unknown
- 1994-03-15 AU AU57832/94A patent/AU668804B2/en not_active Expired
- 1994-03-15 JP JP6044091A patent/JP2568474B2/ja not_active Expired - Lifetime
- 1994-08-29 US US08/298,479 patent/US5514650A/en not_active Expired - Lifetime
- 1994-10-03 UA UA95094151A patent/UA59329C2/uk unknown
-
1995
- 1995-06-29 HU HU95P/P00565P patent/HU211890A9/hu unknown
- 1995-09-13 BG BG99999A patent/BG63047B1/bg unknown
- 1995-09-14 FI FI954327A patent/FI109542B/fi not_active IP Right Cessation
- 1995-09-15 NO NO19953648A patent/NO318372B1/no not_active IP Right Cessation
-
1996
- 1996-10-28 US US08/741,645 patent/US5792746A/en not_active Expired - Lifetime
-
1997
- 1997-04-16 BR BR1100273-5A patent/BR1100273A/pt active IP Right Grant
-
1998
- 1998-07-20 HK HK98109267A patent/HK1008674A1/xx not_active IP Right Cessation
-
1999
- 1999-11-18 GR GR990402878T patent/GR3031872T3/el unknown
-
2000
- 2000-09-07 LV LVP-00-119A patent/LV12574B/en unknown
-
2001
- 2001-12-18 NL NL300076C patent/NL300076I2/nl unknown
-
2002
- 2002-01-03 LU LU90875C patent/LU90875I2/xx unknown
-
2005
- 2005-09-13 NO NO2005020C patent/NO2005020I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0620232B1 (fr) | Aza-cyclohexapeptides | |
EP0805685B1 (fr) | Nouveaux cyclohexapeptides antifongiques | |
US5516756A (en) | Aza cyclohexapeptide compounds | |
EP0781141B1 (fr) | Composes azacyclohexapeptides | |
US5514651A (en) | Aza cyclohexapeptide compounds | |
US5399552A (en) | Antibiotic peptides bearing aminoalkylthioether moieties | |
US5914313A (en) | 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof | |
CA2080756A1 (fr) | 1-¬4-hydroxy-5-aminoethyloxy-n2-(10,12-dimethyl-1-oxotetraecyl)ornithine|-5(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandine | |
CA2197209C (fr) | Composes de type azacyclohexapeptide | |
US5854212A (en) | Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use | |
EP0862579A1 (fr) | Compose de cyclohexapeptidyle bisamine, compositions contenant ce compose et procedes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
RH | Patent void | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |